Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study by H.M. Schenker, K. Tascilar, L. Konerth, M. Sergeeva, J. Prade, S. Strobelt, A. Kleyer, D. Simon, L. Mendez, M. Hagen, V. Schönau, A. Hueber, J. Roesch, A. Dörfler, A. Hess, G. Schett, J. Rech

Get full text